On 17 November, the French subsidiary of U.S. pharmaceutical Abbott has announced to its works council the sale of R&D Laboratories Fournier (300 employees) affecting 200 employees. Laboratories Fournier will be sold to the newly created company Inventiva. A social plan will be launched promoting internal and external mobility. 60 employees could make the choice of a voluntary departure in form of an early retirement plan.
Abott plans to support Inventiva financially for the coming 5 years and will sign two contracts with Inventiva in order to commit the new company to research for Abott. The aim of the new company is "to have very quickly a leading position in external research companies », according to Abott.